# OnCo record nested-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nested-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nested-therapeutics" ;
  schema:name "Nested Therapeutics"@en ;
  schema:description "Nested Therapeutics hunts for hidden cancer-driving mutations and designs drugs to fit them. Its first drug, NST-628, sticks two signalling proteins (RAF and MEK) together to switch off a common cancer growth pathway."@en ;
  schema:url <https://onco.cc/companies/nested-therapeutics/>, <https://nestedtx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://nestedtx.com/>, <https://nestedtx.com/wp-content/uploads/2022/09/Nested-Launches-With-125-Million-Financing.pdf>, <https://clinicaltrials.gov/study/NCT06326411> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/ai-drug-design/> ;
  onco:targets <https://onco.cc/targets/braf/>, <https://onco.cc/targets/tp53/> .